Send us a link
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Funders should not support policy-relevant work that treats policy impact as an afterthought.
London’s loss, as a result of Brexit vote, is lamented by U.K. researchers
The active participation of the people is one of the central components of a functioning democracy. Research performed a real-world randomized experiment in the United States to understand the causal effect of news stories on increasing public discussion of a specific topic.
Patrick Vallance to take over from interim government adviser Chris Whitty from March next year.
Recommendations by G7 to rewarding and incentivize Open Science practices and infrastructures for optimal use of research data.
A systematic review
Nowhere near enough new drugs are currently in development says a WHO report, which calls for urgent investment and responsible use of existing antibiotics.
A number of authors interested in how to translate evidence into policy identify the importance of policy narrative and argue that advocates of scientific evidence need to tell good stories to grab the attention and appeal to the emotions of policymakers.
Why breaking down walls between different academic disciplines could enhance our understanding of why research evidence does − or doesn’t − make it into policy.
Public rejection might just be part of the journey to knowledge's acceptance.
Patients can plead their case for damages even in the absence of scientific evidence, European Court of Justice rules
Feeding high-quality evidence into policy making remains difficult, but is essential for improving public interventions.
With algorithms in hand, scientists are looking to make elections in the United States more representative.
A SPARC analysis of Open Data and Open Science policies across Europe.
